Hudson Edge Investment Partners Inc. Trims Stake in Applied Materials ...
π Hudson Edge Investment Partners Inc. trimmed its Applied Materials stake by 38.9% in Q1, reducing holdings to 17,044 shares worth $5.825 million.
π Vanguard Group increased its position by 0.4% to own 76.78 million shares valued at $19.73 billion.
π Capital Research Global Investors significantly boosted its stake by 119.8%, acquiring an additional 17.83 million shares.
π Major institutional holders now include Ameriprise Financial, Morgan Stanley, and Norges Bank, with hedge funds controlling 80.56% of the float.
π° The company declared a quarterly dividend of $0.53 per share payable on September 10th to shareholders of record on August 20th.
π Analysts have recently raised price targets, with UBS setting a new objective of $570 and Barclays at $590.
π¦ Applied Materials maintains a robust financial profile with a market cap of $478.79 billion and a P/E ratio of 56.62.
π Corporate insiders sold approximately 278,088 shares valued at $169.65 million over the last ninety days.
π The stock currently trades above its 50-day moving average of $499.51 and 200-day moving average of $390.89.
- Major institutional investors like Capital Research Global Investors and Vanguard Group are increasing their stakes, indicating strong long-term confidence in the company's semiconductor equipment business.
- Recent analyst upgrades from UBS, Barclays, and Goldman Sachs have raised price targets to $570, $590, and $520 respectively, reflecting optimism about future earnings potential.
- The company demonstrates a healthy balance sheet with a low debt-to-equity ratio of 0.22 and strong liquidity metrics including a current ratio of 2.51.
- Applied Materials maintains a consistent dividend policy with a declared quarterly payout of $0.53, providing income to shareholders while retaining capital for growth.
- Corporate insiders, including the Director and SVP, have collectively sold over $169 million worth of stock in the last ninety days, which may signal reduced near-term confidence or portfolio rebalancing.
- Morgan Stanley recently restated its rating to 'Equal Weight' with a price target of $502, suggesting some analysts view the current valuation as fair rather than overvalued.